A global pharmaceutical company focused on women’s health, biosimilars, and a portfolio of established medicines that were largely spun out of Merck in 2021. Its products include contraception, fertility treatments, and legacy cardiovascular and respiratory drugs that generate steady cash flow acros...
This page tracks all publicly disclosed congressional trades in Organon & Co. (OGN), a company in the Healthcare sector. 4 members of Congress have disclosed trades in this stock, including 5 purchases and 8 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-26 | Rohit Khanna | buy | $1K – $15K |
| 2023-12-04 | Rohit Khanna | buy | $1K – $15K |
| 2023-11-03 | Rohit Khanna | sell | $1K – $15K |
| 2023-10-02 | Rohit Khanna | buy | $1K – $15K |
| 2023-07-28 | Rohit Khanna | buy | $1K – $15K |
| 2023-06-29 | Rohit Khanna | sell | $1K – $15K |
| 2022-08-02 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2022-05-13 | Rohit Khanna | buy | $1K – $15K |
| 2022-04-13 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2021-06-28 | John W Hickenlooper | sell | $1K – $15K |
| 2021-06-08 | Scott Franklin | sell | $1K – $15K |
| 2021-06-08 | Scott Franklin | sell | $15K – $50K |
| 2021-03-17 | MICHAEL T. MCCAUL | sell | $15K – $50K |